Health and Healthcare
Health and Healthcare Articles
Announcements that Alexion Pharmaceuticals made at its virtual Investor Day about expanding its pipeline and its guidance led to a handy gain in its shares on Tuesday.
Published:
Vir Biotechnology shares jumped on Tuesday after the firm announced that it would be expanding its late-stage COVID-19 study in conjunction with GlaxoSmithKline.
Published:
Many health care products become much more popular because of endorsements and advertising efforts. It is a longstanding practice that has come under fire by both political parties in the United...
Published:
ImmunoGen shares pushed higher to start out the week when the FDA provided an update for the firm’s treatment of patients with relapsed or refractory blastic plasmacytoid dendritic cell neoplasm.
Published:
Corvus Pharmaceuticals shares were sharply higher on Monday after the company announced updated data from its ongoing early-stage study in patients with COVID-19.
Published:
MyoKardia shares hit an all-time high early on Monday after it was announced that Bristol-Myers Squibb would be acquiring the company.
Published:
These five high-conviction medical technology health care ideas from Jefferies all make sense for investors looking to gain exposure to a sector that should continue to do well during the fourth...
Published:
As COVID-19 begins to spread in New York City for a second time this year, hotspots have developed in over a dozen ZIP codes.
Published:
President Trump and the First Lady have tested positive for COVID-19. That begs the question, now more than ever, of where we stand with a coronavirus vaccine.
Published:
Solid Biosciences shares more than doubled on Thursday after the company announced a key update from the FDA.
Published:
Compared to the office and retail real estate investment trusts, which have been hit hard during the pandemic, the medical office REITs have held up extremely well, and investors are starting to...
Published:
Last Updated:
Moderna and Regeneron Pharmaceuticals each announced positive news late on Tuesday about their respective COVID-19 vaccine trials.
Published:
These companies have a very good shot at crossing the finish line first with a COVID-19 vaccine. Even those that won't also have huge product lines and robust pipelines with future drug potential and...
Published:
Aptorum shares absolutely exploded on Tuesday after the company announced that it would be launching a subsidiary focused on novel technologies targeting infectious diseases.
Published:
Almost 6 million Americans 65 and older are living with Alzheimer’s disease. In one state, the number is expected to increase by a third in the next five years.
Published:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.